Drug Trial Radar · NCT03416530
ONC201 in Pediatric H3 K27M Gliomas
Last checked: Nov 19, 2026Latest source record: Feb 14, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
134
Actual
Start
Jan 25, 2018
Primary completion
Dec 31, 2022
Study completion May 24, 2023
Sponsor
- Lead sponsor
- Jazz PharmaceuticalsJazz Pharmaceuticals (JAZZ)
- Sponsor type
- Industry
- Collaborators
- Oncoceutics, Inc.
- First posted
- Jan 31, 2018
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 2 years, up to 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This was a Phase 1, open label, multicenter, 8-arm, dose escalation study of dordaviprone (ONC201) in pediatric patients with newly diagnosed diffuse intrinsic pontine glioma (DIPG) and recurrent/refractory H3 K27M-mutant gliomas. The primary endpoint of this study was to determine the recommended Phase 2 dose (RP2D) of dordaviprone (ONC201) in pediatric glioma patients as a single agent in combination with radiation.
Conditions
- Diffuse Intrinsic Pontine Glioma
- Glioma, Malignant
Interventions
Dordaviprone (ONC201)Drug
Dordaviprone is a brain-penetrant, small-molecule imipridone that acts as a mitochondrial caseinolytic protease P (ClpP) agonist and a dopamine receptor D2 (DRD2) antagonist.
Primary outcomes
What the sponsor says the trial is designed to measure.
- RP2DTime frame: 28 days
Locations
8 sites in 1 country. Site status is shown where the registry gives one.
UCSF, Benioff Children's Hospital
San Francisco, California
Miami Cancer Institute
Miami, Florida
Children's Healthcare of Atlanta, Emory University School of Medicine
Atlanta, Georgia
University of Michigan Cancer Center
Ann Arbor, Michigan
New York University
New York, New York
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio
MD Anderson Cancer Center
Houston, Texas
Seattle Children's Hospital
Seattle, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.